-
Sorafenib Continuation after First Disease Progression Could Reduce Disease Flares and Provide Survival Benefits in Patients with Hepatocellular Carcinoma: a Pilot Retrospective Study
-
Fu, Si-Rui
Zhang, Ying-Qiang
Zhan, Mei-Xiao
Lu, Li-Gong
Li, Yong
Li, Jia-Ping
Huang, Jian-Wen
Hu, Bao-Shan
He, Xu
아시아태평양암예방학회[2014]
Google Scholar네이버 전문정보
|
|
|
|
